Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7359 p103
23 July 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Society national boards plan wins broad support

Each of the three home countries would have a national board

Each of the three home countries would have a national board

National boards for the Royal Pharmaceutical Society in England, Scotland and Wales have been broadly supported by the Company Chemists’ Association, the Guild of Healthcare Pharmacists, the National Pharmacy Association and the Pharmaceutical Services Negotiating Committee.

The organisations argue in their responses to the Society’s consultation, which closed this week, that the Society risks losing influence and relevance if it does not tackle the issue of devolution.

The CCA says that a failure to implement the Society’s proposals would risk compromising decision-making and appropriate representation. The Society would then, the GHP contends, “have little influence on the pharmacy and medicines agenda in Scotland and Wales at a time when health policy is diverging in the home countries”.

The CCA, GHP and PSNC all, however, believe that the establishment of national boards should be cost neutral, and the NPA urges that “it is essential that every effort is made to keep increase in costs to a minimum”. All four organisations highlight the importance of pharmacists from across the whole profession being properly represented. The CCA says it will support the proposal to establish three national boards “if the boards were to be representative of pharmacy as a whole, with some allocated or reserved places for specific sectors, ensuring that the necessary skills sets are represented”.

The GHP agrees that the different sectors of the profession all need to be represented: “There should also be a few places reserved for the different broad areas of practice such as hospital, primary care and public health, to enable a full and proper debate on professional issues, and to ensure the whole membership is represented.”

The PSNC says that board members must have real expertise and command respect. This, it argues, will only be achieved “by having measures to allow each identified sector to elect or appoint its representative(s), and to ensure that meetings are focused and relevant, and not too burdensome in terms of time”.

The CCA suggests that a Society Council member, recognised as a national representative, be on each board, alongside three representatives of different sectors of pharmacy, three members to ensure a range of skill sets, three elected members, a registered pharmacy technician and a lay person. However, both the GHP and the NPA reject the need for any lay representation on the boards.

Back to Top


©The Pharmaceutical Journal